Group B streptococci in human disease.

Bacteriological Reviews Pub Date : 1976-09-01 DOI:10.1128/MMBR.40.3.774-792.1976

M. Patterson, A. El Batool Hafeez

{"title":"Group B streptococci in human disease.","authors":"M. Patterson, A. El Batool Hafeez","doi":"10.1128/MMBR.40.3.774-792.1976","DOIUrl":null,"url":null,"abstract":"INTRODUCTION .............................. 774 History and Nomenclature .............................. 774 Human Disease .............................. 774 THE AGENT .............................. 775 Strains of Bovine and Human Origin ............ .................. 775 Seroclassification .............................. 775 Virulence Factors .............................. 776 Metabolism .............................. 777 CLINICAL DISEASE SPECTRUM ......... ..................... 777 Early Recognition ............................. 777 Neonatal Disease .............................. 778 Disease in Older Children and Adults .......... ................... 779 PATHOGENESIS .............................. 779 Perinatal Colonization .............................. 779 Postnatal Colonization ............................. 780 LABORATORY DIAGNOSIS ............................. 780 Selective Broth Medium for Primary Isolation ................................. 780 Presumptive Identification ............ ......................... 781 Serological Identification .......... ........................... 782 IMMUNOLOGY ...................................... 782 Host Antibody Response .......... ........................... 782 Leukocytic Response ........ ............................. 783 EPIDEMIOLOGY ...................................... 783 Incidence ...................................... 783 Source ...................................... 784 Transmission ...................................... 784 Microbial Persistence ......... ............................ 784 Race ...................................... 785 Sex ..................................... 785 Other Factors ...................................... 785 PROPHYLAXIS AND TREATMENT ...................................... 785 Spectrum of Antimicrobial Susceptibility ..................................... 785 Carrier Prophylaxis ..................................... 785 CONCLUDING REMARKS .......... ........................... 787 LITERATURE CITED ........ ............................. 787","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":"40 3 1","pages":"774-92"},"PeriodicalIF":0.0000,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"69","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bacteriological Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1128/MMBR.40.3.774-792.1976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 69

Abstract

INTRODUCTION .............................. 774 History and Nomenclature .............................. 774 Human Disease .............................. 774 THE AGENT .............................. 775 Strains of Bovine and Human Origin ............ .................. 775 Seroclassification .............................. 775 Virulence Factors .............................. 776 Metabolism .............................. 777 CLINICAL DISEASE SPECTRUM ......... ..................... 777 Early Recognition ............................. 777 Neonatal Disease .............................. 778 Disease in Older Children and Adults .......... ................... 779 PATHOGENESIS .............................. 779 Perinatal Colonization .............................. 779 Postnatal Colonization ............................. 780 LABORATORY DIAGNOSIS ............................. 780 Selective Broth Medium for Primary Isolation ................................. 780 Presumptive Identification ............ ......................... 781 Serological Identification .......... ........................... 782 IMMUNOLOGY ...................................... 782 Host Antibody Response .......... ........................... 782 Leukocytic Response ........ ............................. 783 EPIDEMIOLOGY ...................................... 783 Incidence ...................................... 783 Source ...................................... 784 Transmission ...................................... 784 Microbial Persistence ......... ............................ 784 Race ...................................... 785 Sex ..................................... 785 Other Factors ...................................... 785 PROPHYLAXIS AND TREATMENT ...................................... 785 Spectrum of Antimicrobial Susceptibility ..................................... 785 Carrier Prophylaxis ..................................... 785 CONCLUDING REMARKS .......... ........................... 787 LITERATURE CITED ........ ............................. 787

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

B群链球菌在人类疾病中的作用。

介绍 ..............................774年历史和术语 ..............................774人类疾病..............................774代理..............................775株的牛和人类的起源 ............ ..................775年Seroclassification ..............................775年毒力因素 ..............................776新陈代谢..............................777年临床疾病谱系 ......... .....................777年早期识别 .............................777年新生儿疾病 ..............................778年疾病在年龄较大的儿童和成年人 .......... ...................779发病机制..............................779年围产期殖民 ..............................779年出生后殖民 .............................780年实验室诊断 .............................780选择性肉汤培养基主要隔离 .................................780年筛检 ............ .........................781年血清学鉴定 .......... ...........................782年免疫学 ......................................782主机抗体反应 .......... ...........................782白血球的响应 ........ .............................783年流行病学 ......................................783年发病率 ......................................783年源 ......................................784年的传播 ......................................784微生物持久性 ......... ............................784种族......................................785性.....................................785年的其他因素 ......................................785预防和治疗 ......................................785年药敏谱 .....................................785年航母预防 .....................................785结束语 .......... ...........................787年文献引用 ........ .............................787

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助